Product Information
ATORVASTATIN 80 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0693 per EA under NDC 70710177009. Its NADAC has been published 111 times since Aug 21, 2024.
FDA first approved this application on Nov 20, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
80 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710177009
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA206536FDA Approved
11/20/2018
TE Code
AB
On Market Since
6/12/2024
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 80 MG TABLET has been published 111 times since Aug 21, 2024, and over the history we have for it it has declined 12.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0693 per EA |
|---|---|
| All-time high | $0.0850 (May 14, 2025) |
| All-time low | $0.0663 (Nov 20, 2024) |
| 52-week high | $0.0728 |
| 52-week low | $0.0692 |
| Median price | $0.0728 |
| Average price | $0.0757 |
| Largest weekly change | -21.1% (Nov 20, 2024) |
| Weeks tracked | 111 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
atorvastatin calcium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATORVASTATIN 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 80 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0693 per EA (NDC 70710177009), effective Sep 30, 2026.
How has the price of ATORVASTATIN 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 80 MG TABLET has declined 12.7%. It has been tracked across 111 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 80 MG TABLET?
Since Aug 21, 2024, the NADAC for ATORVASTATIN 80 MG TABLET has ranged from a low of $0.0663 (Nov 20, 2024) to a high of $0.0850 (May 14, 2025), with a median of $0.0728 per EA.
Are there cheaper alternatives to ATORVASTATIN 80 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATORVASTATIN 80 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ATORVASTATIN 80 MG TABLET?
ATORVASTATIN 80 MG TABLET (NDC 70710177009) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.